Home › Markets › Health Care › ELTX

Elicio Therapeutics Inc. (ELTX)

ELTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.77
-5.85% on the day
Market cap
$48.0M
Nano cap
Revenue
No annual revenue filed since the period ending 2022-12-31
Net income
No annual revenue filed since the period ending 2022-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerELTX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001601485
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue filed since the period ending 2022-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-07-02
Latest annual report10-K/A2026-04-29
Latest quarterly / interim10-Q2026-08-13
Latest current report8-K2026-09-14
Latest proxyDEF 14A2026-10-09

Source: SEC EDGAR submissions feed, 382 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ACETAdicet Bio Inc.$5.11-7.59%$47.8M
HOWLWerewolf Therapeutics Inc.$0.9911+0.95%$48.2M
CLNNClene Inc.$3.39-7.88%$48.2M
SERSerina Therapeutics Inc.$1.82-6.19%$46.2M
CELUCelularity Inc.$1.42-3.40%$46.1M
IBIOiBio Inc.$0.7818-13.44%$50.3M
ANVSAnnovis Bio Inc.$1.06-7.83%$45.2M
MREOMereo BioPharma Group plc$0.3200+1.52%$51.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier